About
Retinal imaging AI detecting diabetic retinopathy and other chronic conditions at scale in China; NMPA Class III certificate for AIFUNDUS 2.0 (April 2025). Listed on HKEX in Nov 2021.
HQ: Beijing, China
Funding
Public (HKEX 2251.HK); ~HK$1.0B market cap recently
—